• Image attribution tooltip
    Retrieved from Abbott/PRNewswire on June 15, 2020

    Abbott, Dexcom could benefit from CGM use jump among Type 2 diabetes patients: report

    The population could drive the next wave of demand for devices to track and control diabetes, Jefferies analysts predict, based on polling of roughly 50 endocrinologists and general practitioners.

    By Oct. 13, 2021
  • Image attribution tooltip
    Hiraman via Getty Images
    Sponsored by IQVIA

    Curating data assets for real-time insights

    With the increasing movement toward digitalization, the competitive landscape is beginning to change.

    Sept. 27, 2021
  • Image attribution tooltip
    Spencer Platt via Getty Images

    Cue, Google's COVID-19 test provider, raises $200M in IPO

    The at-home test maker will use the money to scale up commercial and manufacturing infrastructure to support its portable diagnostic platform. Cue Health's Friday debut on the Nasdaq valued the company at $2.9 billion.

    By Sept. 27, 2021
  • ResMed touts CPAP survival benefits for sleep apnea after HHS doubts therapy efficacy

    The ResMed-funded analysis of a French database comes on the heels of a government review finding the evidence does not back a link between continuous positive airway pressure therapy and clinically important outcomes.

    By Sept. 9, 2021
  • Image attribution tooltip


    Hospital telehealth leveling off at one-fifth of medical appointments, research finds

    And of the facilities reporting higher virtual volumes, many said they expected telehealth use to decline over the long term, according to the survey from KLAS Research and the Center for Connected Medicine.

    By Rebecca Pifer • Sept. 8, 2021
  • Image attribution tooltip
    Master Sgt. Hecht, Matt. (2020). [Photograph]. Retrieved from Flickr.

    Pandemic spurs rise of other infections contracted at healthcare facilities

    The largest increase at hospitals from 2019 to 2020 was seen in bloodstream infections associated with central line catheters, according to the CDC.

    By Hailey Mensik • Sept. 2, 2021
  • Image attribution tooltip
    Christopher Furlong via Getty Images

    Smoking pot before knee, hip replacements linked with more complications

    With marijuana use rising quickly in U.S. adults aged 45 to 64 years, three studies presented at the American Academy of Orthopaedic Surgeons meeting sought to find out if consumption affects outcomes.

    By Sept. 2, 2021
  • Image attribution tooltip
    Courtesy of Abbott

    Abbott predicted to quickly take share from Boston Scientific's Watchman: survey

    The poll of 56 electrophysiologists by SVB Leerink analysts is somewhat more encouraging for Boston Scientific than an earlier survey, but still highlights the threat to the franchise as it loses its monopoly in the space.

    By Aug. 26, 2021
  • Image attribution tooltip

    Patients were still hesitant to seek medical care out of virus fears this spring, survey finds

    Despite reopenings, one in 10 nonelderly adults put off needed medical care this spring, an April survey from the Urban Institute found.

    By Hailey Mensik • Aug. 19, 2021
  • Image attribution tooltip

    Outpatient revenue drives hospital volume rebound in June, Kaufman Hall says

    The report's year-to-date trends in outpatient visit growth add to color from medtech companies reporting electives rebounding in recent financial results.

    By Hailey Mensik • Aug. 4, 2021
  • Mayo Clinic named U.S. News top hospital for sixth straight year

    The list, which already examines specialty areas like knee replacements, added seven new measures including care for spinal fusion and hip fracture.

    By Shannon Muchmore • July 28, 2021
  • Image attribution tooltip
    Adobe Stock

    PerkinElmer inks $5.3B takeover of antibody provider BioLegend

    Flush with revenue from COVID-19 testing, the medtech is betting the company can sustain a high growth rate amid competition from BD and Thermo Fisher.

    By July 27, 2021
  • Image attribution tooltip
    Adeline Kon/Healthcare Dive/MedTech Dive
    Deep Dive

    Medtech pay to doctors plunged in 2020 as COVID-19 pummeled electives, in-person services fell

    Zimmer Biomet had the biggest drop, cutting general payments nearly 80% to $63 million. Other notable decreases include Stryker, J&J's DePuy Synthes and Boston Scientific.

    By July 12, 2021
  • Image attribution tooltip
    Permission granted by The Boldt. Co.

    U.S. News hospital rankings to add back surgery, hip fracture and overuse

    The publication will rank seven new procedures and conditions, as well as a new category "because a pattern of overuse or low-value care is not compatible with being a high-quality provider."

    By Hailey Mensik • June 30, 2021
  • Image attribution tooltip
    Adeline Kon/MedTech Dive

    Black patients were more likely to die of COVID-19 largely due to inferior hospitals

    A recent study in JAMA Network Open showed how inequities in housing influence where Black people seek care and how that affects the quality of care they receive.

    By Samantha Liss • June 21, 2021
  • Image attribution tooltip
    National Cancer Institute, NIH

    In first, FDA approves KRAS-blocking cancer drug from Amgen

    After decades of scientists unsuccessfully targeting the KRAS gene, Lumakras is the first drug proven effective. The FDA Friday also approved companion diagnostics from Qiagen and Guardant Health.

    By Ned Pagliarulo • Updated May 29, 2021
  • Image attribution tooltip
    Courtesy of Boston Scientific

    Boston Scientific's Watchman shows low stroke rate in large registry at ACC

    The fast-growing product performed well in an analysis of more than 36,000 people presented at the American College of Cardiology meeting, with low adverse event rates that surprised even the study's author.

    By May 17, 2021
  • Image attribution tooltip
    Sarah Silbiger via Getty Images

    Paclitaxel, uncoated stents for PAD show similar mortality in real world study

    The review of outcomes for Medicare beneficiaries contrasts a 2018 meta-analysis that identified a mortality signal for patients treated with drug-coated stents and balloons. Still, JAMA editors said mortality rates are troublingly high.

    By May 17, 2021
  • Image attribution tooltip
    Courtesy of Boston Scientific

    TAVR readmission rates vary widely between hospitals for unknown reasons: study

    Length of stay and discharge disposition only explained 15% of the inter-hospital variation. The study's authors have called for efforts to identify practices associated with low rates or readmission. 

    By May 10, 2021
  • EU MDR delay has not made new rules easier to stomach: exec poll

    Most of the 115 respondents to the Climedo Health survey said resources and lack of clarity were top challenges, with about a third indicating compliance efforts will cost their company 5% to 10% of annual revenue.

    By April 15, 2021
  • Image attribution tooltip
    Adobe Stock

    Fewer heart tests ordered for telehealth patients in pandemic

    Research published in JAMA Network Open also found those using the virtual services were more likely to be Asian, Black or Hispanic.

    By April 6, 2021
  • Medtechs top pharma in cash to doctors for consulting, travel: Health Affairs study

    The majority of sector payments, also covering royalties, speaking fees and food, came from the likes of Medtronic, J&J, Zimmer, Stryker and Abbott. Specialties targeted included neurosurgery, orthopaedics and cardiology. 

    By April 6, 2021
  • Image attribution tooltip
    Alex Wong via Getty Images

    Hospitals flailed amid COVID-19 crisis, are unsure of future, OIG says

    Executives said they were worried about their workers experiencing trauma and concerned a shrinking recruitment pool for nurses could exacerbate staffing shortages.

    By Ron Shinkman • March 25, 2021
  • AstraZeneca, Oxford vaccine prevents COVID-19 in big US study amid controversy overseas

    A two-shot regimen was 79% effective at protecting people from COVID-19, which should support the fourth clearance of a vaccine in the U.S. and calm safety concerns abroad. 

    By Ben Fidler • March 22, 2021
  • Insulin pump adoption seen climbing 21% in 2021 on wearables boom: survey

    The SVB Leerink poll of 101 endocrinologists and nurse practitioners also projects a shift in market position among top players like Medtronic, Insulet and Tandem Diabetes Care.

    By March 5, 2021